Abstract
We retrospectively reviewed 27 cases diagnosed as idiopathic optic neuritis between 1992 and 2001 at Kaohsiung Veterans General Hospital to assess the clinical features, visual prognosis, neuroimaging, laboratory studies, and development of multiple sclerosis in Chinese patients with optic neuritis. Patient age ranged from 13 to 54 years (mean, 35.8 ± 11.3 years). Five cases presented as bilateral optic neuritis and 22 as unilateral. Visual function improved gradually from 2 weeks after treatment. Twelve (44.4%) cases showed disc swelling and ocular pain was also noted in 44.4% of patients. All cases that underwent visual field and visual evoked potential tests showed abnormality in lesion eyes. Of the 23 cases that underwent neuroimaging studies, including computerized tomography (17 patients) and magnetic resonance imaging (6 patients), 10 revealed optic nerve thickening. Four cases (14.8%) developed multiple sclerosis during follow‐up (mean, 4.3 years). The incidence of disc swelling was higher than that reported by the Optic Neuritis Treatment Trial, but the incidence of initial ocular pain, the presence of periventricular plaques, and the development of multiple sclerosis were lower in our study. The unilateral group had significantly better visual outcome than the bilateral group.
Keywords: optic neuritis, Chinese, multiple sclerosis
Full Text
The Full Text of this article is available as a PDF (120.2 KB).
References
- 1. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med. 1993; 329: 1746–1769. [DOI] [PubMed] [Google Scholar]
- 2. Perkin GD, Rose FC. Optic Neuritis and its Differential Diagnosis. New York: Oxford University Press. 1979. [Google Scholar]
- 3. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992; 326: 581–588. [DOI] [PubMed] [Google Scholar]
- 4. Barlow JS. Multiple sclerosis in North Korea and China. Neurology. 1967; 17: 802.15088542 [Google Scholar]
- 5. Lin JC, Jou JR, Liaw SL, et al. Magnetic resonance imaging and computed tomography in optic neuritis. Acta Soc Ophthalmol Sin. 1996; 35: 57–62. [Google Scholar]
- 6. Beck RW, Cleary PA, Backlund JC, The Optic Neuritis Study Group , et al. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology. 1994; 101: 1771–1778. [DOI] [PubMed] [Google Scholar]
- 7. Wakakura M, Mashimo K, Oono S, et al. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Jpn J Ophthalmol. 1999; 43: 133–138. [DOI] [PubMed] [Google Scholar]
- 8. Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1993; 111: 231–234. [DOI] [PubMed] [Google Scholar]
- 9. Optic Neuritis Study Group . The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991; 109: 1673–1678. [DOI] [PubMed] [Google Scholar]
- 10. Wakakura M, Minei‐Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol. 1999; 43: 127–132. [DOI] [PubMed] [Google Scholar]
- 11. Fang JP, Donahue SP, Lin RH. Global visual field involvement in acute unilateral optic neuritis. Am J Ophthalmol. 1999; 128: 554–565. [DOI] [PubMed] [Google Scholar]
- 12. Frederiksen JL, Petrera J. Serial visual evoked potential in 90 untreated patients with acute optic neuritis. Surv Ophthalmol. 1999; 44 (Suppl 1): S54–S62. [DOI] [PubMed] [Google Scholar]
- 13. Trauzettel‐Klosinski S, Diener HC, Dietz K, Zrenner E. The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study. Doc Ophthalmol. 1996; 91: 165–179. [DOI] [PubMed] [Google Scholar]
- 14. Slamovits TL, Beck RW, Frenkel M. What to tell the patient with optic neuritis about multiple sclerosis. Surv Ophthalmol. 1991; 36: 47–50. [DOI] [PubMed] [Google Scholar]
- 15. Optic Neuritis Study Group . The 5‐year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology. 1997; 49: 1404–1413. [DOI] [PubMed] [Google Scholar]
- 16. Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population‐based study in Olmsted County, Minnesota. Neurology. 1995; 45: 244–250. [DOI] [PubMed] [Google Scholar]
- 17. Francis DA, Compston DAS, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow‐up. J Neurol Neurosurg Psychiatry. 1987; 50: 758–765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Frith JA, McLeod JG, Hely M. Acute optic neuritis in Australia: a 13 year prospective study. J Neurol Neurosurg Psychiatry. 2000; 68: 246–251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Sandberg‐Wollheim M, Bynke H, Cronqvist S, et al. A long‐term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990; 27: 386–393. [DOI] [PubMed] [Google Scholar]
- 20. Alter M, Good J, Okihiro M. Optic neuritis in Orientals and Caucasians. Neurology. 1973; 23: 631–639. [DOI] [PubMed] [Google Scholar]
- 21. Trobe JD. High‐dose corticosteroid regimen retards development of multiple sclerosis in Optic Neuritis Treatment Trial. Arch Ophthalmol. 1994; 112: 35–36. [DOI] [PubMed] [Google Scholar]
- 22. Beck RW, Kupersmith MJ, Gleary PA, Katz B. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. Ophthalmology. 1993; 100: 691–697. [DOI] [PubMed] [Google Scholar]
- 23. Beck RW, Cleary PA. Optic Neuritis Treatment Trial. One‐year follow‐up results. Arch Ophthalmol. 1993; 111: 773–775. [DOI] [PubMed] [Google Scholar]
- 24. Chrousos GA, Kattah JC, Beck RW, et al. Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA. 1993; 269: 2110–2112. [PubMed] [Google Scholar]